Next: About this document Up: No Title Previous: No Title

References

1
G. J. Barton and M. J. E. Sternberg. A strategy for the rapid multiple alignment of protein sequences: Confidence levels from tertiary structure comparisons. J. Mol. Biol, 198:327-337, 1987.

2
G.J. Barton. Protein multiple sequence alignment and flexible pattern matching. Methods Enzymol., 183:403-428, 1990.

3
C. Desgranges. Catabolism of thymidine in human blood platelets purification and properties of thymidine phosphorylase. Biochim. Biophys. Acta, 654:211-218, 1981.

4
C. Desgranges, G. Razaka, M. Rabaud, H. Bricaud, J. Balzarini, and E.D. Clercq. Phosphorolysis of (e)-5-(2-bromovinyl)-2-deoxyuridine (bvdu) and other 5-substituted-2-deoxyuridines by purified thymidine phosphorylase and intact blood platelets. Biochem. Pharmacol., 32:3583-3590, 1983.

5
C. Finnis, A. Goodey, M. Courtney, and D. Sleep. Expression of recombinant platelet derived endothelial cell growth factor in the yeast s. cerevisiae. Yeast, 8:57-60, 1992.

6
C-H. Heldin, Å. Wasteson, and B. Westermark. Partial purification and characterization of platelet factors stimulating the multiplication of normal human glial cells. Exp. Cell Res., 109:429-437, 1977.

7
F. Ishikawa, K. Miyazono, U. Hellman, H. Drexler, C. Wernstadt, K. Hagiwara, K. Usuki, F. Takaku, W. Risau, and C-H. Heldin. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature, 338:557-562, 1989.

8
G. L. King and S. Buchwald. Characterisation and partial purification of an endothelial cell growth factor from human platelets. J. Clin. Invest., 73:392-396, 1984.

9
K. Miyazono and C-H. Heldin. High-yield purification of platelet-derived endothelial cell growth factor: structural characterization and establishment of a specific antiserum. Biochemistry, 28:1704-1710, 1989.

10
K. Miyazono, T. Okabe, A. Urabe, F. Takaku, and C-H. Heldin. Purification and properties of an endothelial cell growth factor from human platelets. J. Biol. Chem., 262:4098-4103, 1987.

11
T. Shaw, R.H. Smillie, and D.G. MacPhee. The role of blood platelets in nucleoside metabolism: assay, cellular location and significance of thymidine phosphorylase in human blood. Mutat. Res., 200:99-116, 1988.

12
T. Shwartz. Thymidine phosphorylase from escherichia coli. Methods Enzymol., 51:442-445, 1978.

13
T. F. Smith and M. S. Waterman. Identification of common molecular subsequences. 147:195-197, 1981.

14
K. Usuki, N-E. Heldin, K. Miyazono, F. Ishikawa, F. Takaku, B. Westermark, and C-H. Heldin. Production of platelet-derived endothelial cell growth factor by normal and transformed human cells in culture. Proc. Natl. Acad. Sci. USA, 86:7427-7431, 1989.

15
K. Usuki, K. Miyazono, and C.H. Heldin. Covalent linkage between nucleotides and platelet-derived endothelial cell growth factor. J. Biol. Chem., 266:20525-20531, 1991.

16
M.R. Walter, W.J. Cook, L.B. Cole, S.A. Short, G.W. Koszalka, T.A. Krenistsky, and S.E. Ealick. Three-dimensional structure of thymidine phosphorylase from escherichia coli at 2.8 å resolution. J. Biol. Chem., 265:14016-14022, 1990.

17
A. Yoshimura, Y. Kuwazuru, T. Furukawa, H. Yoshida, K. Yamada, and S. Akiyama. Purification and tissue distribution of human thymidine phosphorylase: high expression in lymphocytes, reticulocytes and tumors. Biochim. Biophys. Acta, 1034:107-113, 1990.


gjb@bioch.ox.ac.uk